71655-103 : Raxibacumab 50 mg/ml Intravenous Injection


NDC: 71655-103
Labeler: Emergent Manufacturing Operations Baltimore LLC
Product Type: Human Prescription Drug
Drug Name: Raxibacumab
Dosage Form: Intravenous Injection
Application #: BLA125349
Rev. Date: 


NDC Package Codes:

  • 71655-103-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (71655‑103‑01) > 34 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Raxibacumab

Dosage Strength:

  • 50 mg/mL

Pharmaceutical Classes:

  • Anthrax Protective Antigen-directed Antibody [EPC]
  • Anthrax Protective Antigen-directed Antibody Interactions [MoA]

Related Products:

Based on records with the same trade name.
  • 49401-103 Raxibacumab 50 mg/ml Intravenous Injection by Human Genome Sciences, Inc.
  • 49401-104 Raxibacumab 50 mg/ml Intravenous Injection by Human Genome Sciences, Inc.
  • 63379-060 Raxibacumab 50 mg/ml Intravenous Injection by Glaxo Operations Uk Ltd
  • 63379-061 Raxibacumab 50 mg/ml Intravenous Injection by Glaxo Operations Uk Ltd

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71655-103 QR Code

< Prev: 71654-005Next: 71656-016 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.